CompetitorsNarrow moat
Procter & Gamble (PG) — moat facet
P&G is worth more than seven listed rivals combined, yet it blamed competitors for lost volume in eight categories in fiscal 2026.
P&G's annual report does not name a single competitor. It says the company competes against "well-known global competitors" and against "retailers' private-label brands", across price tiers from super-premium to value1. The competition shows up instead in the explanations of lost volume: in fiscal 2026 the 10-K cited competitive activity in eight categories, from North American hair care to Greater China skin care2.
The rivals fall into four different kinds of relationship. The listed consumer-goods peers are head-on competitors, and P&G's market value of $339.64 billion3 exceeds the combined value of seven of them, $335.69 billion45. The retailer's own label is a competitor that is also P&G's customer. Clorox was a partner in the Glad joint venture until January 2026, when it bought P&G's stake6. And in Greater China P&G loses share to rivals it does not identify at all7.
What these relationships have in common is that none of them threatens P&G's position all at once. The pressure is a half point here and a promotion there. It is expensive to answer: marketing rose 80 basis points as a share of sales in fiscal 20268, and in the June 2026 quarter P&G reinvested 410 basis points, primarily in marketing9.
P&G sets itself a competitive target in shareholder terms. Its stated aim is total shareholder return "in the top one-third of our peer group"10. Over the five years to June 2026 its shares returned $123 for every $100, against $145 for the S&P 500 Consumer Staples index11, so on the broader sector measure the competitive position has not translated into returns.
The verdict on competition is a leader that is being contested widely but shallowly. The number that would change it is the count of categories where P&G blames competitive activity for lost volume; eight in fiscal 202612, and a longer list next year with aggregate share falling again would mean the contest has become broad enough to cost margin every year.
Share held or grew in 26 of top 50 combinations; competitive activity cited in 8 categories.
The breadth of competitive pressure; a longer list next year would mean the contest is widening.
Source: P&G Form 10-K, FY2026 ↗- ReportedIt says the company competes against "well-known global competitors" and against "retailers' private-label brands", across price tiers from super-premium to value.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 1 business and Item 2 properties: employees, manufacturing sites, customers, channels, competition and strategy. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedThe competition shows up instead in the explanations of lost volume: in fiscal 2026 the 10-K cited competitive activity in eight categories, from North American hair care to Greater China skin care.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A: market shares and competitive activity by category. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedThe listed consumer-goods peers are head-on competitors, and P&G's market value of $339.64 billion exceeds the combined value of seven of them, $335.69 billion.Procter & Gamble (PG) market data - $146.23 at the close on 25 September 2026, market cap $339.64B, 52-week range 137.62-167.25, analyst target $160.61. — September 2026 · publ. 25 September 2026 · source ↗
- ReportedThe listed consumer-goods peers are head-on competitors, and P&G's market value of $339.64 billion exceeds the combined value of seven of them, $335.69 billion.Procter & Gamble market capitalisation history and peer market values (year-end 2015-2025; Unilever, Colgate-Palmolive, Kenvue, Estee Lauder, Kimberly-Clark, Church & Dwight, Clorox on 25 September 2026). — 2015-2026 · publ. September 2026 · source ↗
- Moat Explorer calcThe listed consumer-goods peers are head-on competitors, and P&G's market value of $339.64 billion exceeds the combined value of seven of them, $335.69 billion.Moat Explorer calculation from Procter & Gamble's reported figures ($ millions unless stated; fiscal years end 30 June). Net debt: FY2026 11,296 + 22,842 - 9,942 = 24,196; 24,196 / 54,311 = 0.45 times equity; 24,196 / 19,556 = 1.24 years of operating cash flow; debt due within one year 11,296 / (11,296 + 22,842) = 33% of debt; FY2025 9,513 + 24,995 - 9,556 = 24,952; FY2024 7,191 + 25,269 - 9,482 = 22,978. Capital spending 4,409 / 87,032 = 5.1% of net sales. Adjusted free cash flow over dividends 15,835 / 10,232 = 1.55 times. Dividends paid over net earnings attributable: 10,232 / 16,046 = 63.8% (FY2026); 9,872 / 15,974 = 61.8% (FY2025); 9,312 / 14,879 = 62.6% (FY2024). Buybacks 5,028 / 11,009 = 45.7% of the FY2021 peak. Peer market values on 25 September 2026 ($bn): 132.99 + 68.60 + 34.19 + 34.18 + 32.74 + 22.86 + 10.13 = 335.69, against P&G 339.64; P&G / Clorox 339.64 / 10.13 = 33.5 times. P/E: 339.64 / 16.046 = 21.2 (now); 394.82 / 14.879 = 26.5 (December 2024 over FY2024). Free cash flow yield 15,835 / 339,640 = 4.7%. Goodwill plus Gillette brand 41,276 + 12,800 = 54,076; 54,076 / 126,521 = 42.7% of total assets. Segments (five reportable, excluding Corporate): FY2026 sales 16,023 + 6,918 + 12,456 + 30,314 + 20,401 = 86,112; net earnings 2,672 + 1,529 + 2,404 + 5,632 + 3,930 = 16,167; FY2025 net earnings 2,715 + 1,577 + 2,440 + 5,848 + 4,013 = 16,593; 16,167 / 16,593 - 1 = -2.6%. Segment net earnings changes FY2026: Beauty 2,672 / 2,715 - 1 = -1.6%; Grooming 1,529 / 1,577 - 1 = -3.0%; Health Care 2,404 / 2,440 - 1 = -1.5%; Fabric & Home Care 5,632 / 5,848 - 1 = -3.7%; Baby, Feminine & Family Care 3,930 / 4,013 - 1 = -2.1%. Fabric & Home Care share of segment net earnings 5,632 / 16,167 = 34.8%. Pre-tax margins FY2026: Beauty 3,473 / 16,023 = 21.7%; Grooming 1,966 / 6,918 = 28.4%; Health Care 3,163 / 12,456 = 25.4%; Fabric & Home Care 7,290 / 30,314 = 24.0%; Baby, Feminine & Family Care 5,145 / 20,401 = 25.2%. Net margins FY2023: Beauty 3,178 / 15,008 = 21.2%; Health Care 2,125 / 11,226 = 18.9%; Fabric & Home Care 4,828 / 28,371 = 17.0%; Baby, Feminine & Family Care 3,545 / 20,217 = 17.5%. Three-year growth FY2023-FY2026: Health Care sales 12,456 / 11,226 - 1 = 11.0%; Health Care net earnings 2,404 / 2,125 - 1 = 13.1%; Grooming sales 6,918 / 6,419 - 1 = 7.8%; Baby, Feminine & Family Care sales 20,401 / 20,217 - 1 = 0.9%. Segment capital spending over sales FY2026: Grooming 540 / 6,918 = 7.8%; Baby, Feminine & Family Care 1,520 / 20,401 = 7.5%; Health Care 592 / 12,456 = 4.8%; Fabric & Home Care 1,250 / 30,314 = 4.1%; Beauty 415 / 16,023 = 2.6%. Geography FY2026 ($bn): international 45.3 / 87.0 = 52.1%; United States 41.7 / 87.0 = 47.9%. Walmart about 16% x 87,032 = 13,925, about $13.9 billion. Top ten customers less Walmart (rounded percentages): FY2017 35 - 16 = 19; FY2020 38 - 15 = 23; FY2023 40 - 15 = 25; FY2026 43 - 16 = 27. Dividend per share 4.2589 / 4.0763 - 1 = 4.5% (FY2026); 4.0763 / 3.8286 - 1 = 6.5% (FY2025). Market exit charges after tax 1,200 + 131 = 1,331. P&G / Unilever market value 339.64 / 132.99 = 2.6 times. Restructuring charges FY2024-FY2026 659 + 1,114 + 1,230 = 3,003. Gillette write-downs 8.3 + 1.3 = 9.6 billion. Operating margin 19,748 / 87,032 = 22.7% (FY2026); 20,451 / 84,284 = 24.3% (FY2025) - balance sheet, cash returns and valuation. — FY2015-FY2026 · publ. September 2026 · source ↗Method: Arithmetic on figures reported in Procter & Gamble's Forms 10-K, results releases, earnings slides and market data; operands shown in the source line.
- ReportedClorox was a partner in the Glad joint venture until January 2026, when it bought P&G's stake.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - notes: restructuring, goodwill and intangibles, acquisitions and divestitures, subsequent events and commitments. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedAnd in Greater China P&G loses share to rivals it does not identify at all.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Note 2 segment information: net sales, earnings before tax, net earnings, margins, capital spending and depreciation by segment. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedIt is expensive to answer: marketing rose 80 basis points as a share of sales in fiscal 2026, and in the June 2026 quarter P&G reinvested 410 basis points, primarily in marketing.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A: net sales drivers, organic sales and gross margin bridge. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedIt is expensive to answer: marketing rose 80 basis points as a share of sales in fiscal 2026, and in the June 2026 quarter P&G reinvested 410 basis points, primarily in marketing.Procter & Gamble fourth-quarter and fiscal 2026 results release, Form 8-K exhibit 99.1, with fiscal 2027 guidance - quarterly and fiscal-year headline results and cash flow. — Q4 FY2026 · publ. 29 July 2026 · source ↗
- ReportedIts stated aim is total shareholder return "in the top one-third of our peer group".Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 1 business and Item 2 properties: employees, manufacturing sites, customers, channels, competition and strategy. — FY2026 · publ. 4 August 2026 · source ↗
- ReportedOver the five years to June 2026 its shares returned $123 for every $100, against $145 for the S&P 500 Consumer Staples index, so on the broader sector measure the competitive position has not translated into returns.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 1A risk factors, Item 5 market information and performance graph, and critical accounting estimates (Gillette brand). — FY2026 · publ. 4 August 2026 · source ↗
- ReportedThe number that would change it is the count of categories where P&G blames competitive activity for lost volume; eight in fiscal 2026, and a longer list next year with aggregate share falling again would mean the contest has become broad enough to cost margin every year.Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A: market shares and competitive activity by category. — FY2026 · publ. 4 August 2026 · source ↗